RT @drdavidliew: ARIAA: saw 18m results #EULAR2022 (alluded to at #ACR21) High-risk ACPA+ clinically suspect arthralgia
Tweet Content
ARIAA: saw 18m results #EULAR2022
(alluded to at #ACR21)
High-risk ACPA+ clinically suspect arthralgias
Didn't progress to arthritis:
after 6m abatacept: 92% vs 65%
12m after abatacept stopped: 65% vs 43%
(tighter at points)
How to pick those that benefit?
POS0531 @RheumNow https://t.co/dkf1jU5gx7
Links
David Liew on Twitter: "Can we stop RA developing? Not previously. …
https://twitter.com/drdavidliew/status/1457010240772132866
Show on Archive Page
On
Display in Search Results
On
PDQ
Off